We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

181 hedge funds and large institutions have $1.73B invested in Nektar Therapeutics in 2015 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 23

38% more call options, than puts

Call options by funds: $6.54M | Put options by funds: $4.74M

24% more capital invested

Capital invested by funds: $1.39B → $1.73B (+$338M)

18% more funds holding

Funds holding: 153 → 181 (+28)

18% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 45

Holders
181
Holders Change
+28
Holders Change %
+18.3%
% of All Funds
4.87%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
51
Increased
53
Reduced
45
Closed
23
Calls
$6.54M
Puts
$4.74M
Net Calls
+$1.8M
Net Calls Change
-$2.58M

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$50.7M
2
First Trust Advisors
First Trust Advisors
Illinois
+$39.3M
3
CCM
Camber Capital Management
Massachusetts
+$17.2M
4
GAM
Gotham Asset Management
New York
+$15.6M
5
BA
BlackRock Advisors
Delaware
+$14.1M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$41.1M
2
BIT
BlackRock Institutional Trust
California
-$13.2M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$11.4M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$7.72M
5
DFO
Duquesne Family Office
New York
-$7.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
FC
76
FIC Capital
New York
$1.73M -$83.1K -483 -5%
ProShare Advisors
77
ProShare Advisors
Maryland
$1.55M -$72.3K -420 -5%
Capital Fund Management (CFM)
78
Capital Fund Management (CFM)
France
$1.51M +$1.38M +8,045 New
GCP
79
GSA Capital Partners
United Kingdom
$1.47M -$75.9K -441 -5%
Wells Fargo
80
Wells Fargo
California
$1.47M +$482K +2,799 +56%
FSA
81
Franklin Street Advisors
North Carolina
$1.43M – – –
AL
82
Airain Ltd
Guernsey
$1.4M +$1.29M +7,468 New
TPSF
83
Texas Permanent School Fund
Texas
$1.4M +$1.28M +7,440 New
HCM
84
Highbridge Capital Management
New York
$1.33M +$1.22M +7,089 New
State of New Jersey Common Pension Fund D
85
State of New Jersey Common Pension Fund D
New Jersey
$1.31M – – –
State Board of Administration of Florida Retirement System
86
State Board of Administration of Florida Retirement System
Florida
$1.3M – – –
State of Tennessee, Department of Treasury
87
State of Tennessee, Department of Treasury
Tennessee
$1.29M +$1.18M +6,867 New
SAM
88
Sectoral Asset Management
Quebec, Canada
$1.25M +$238K +1,383 +26%
AIG
89
American International Group
New York
$1.19M +$161K +937 +17%
US Bancorp
90
US Bancorp
Minnesota
$1.19M – – –
MLICM
91
Metropolitan Life Insurance Company (MetLife)
New York
$1.17M -$46.8K -272 -4%
WC
92
Wexford Capital
Florida
$1.13M +$1.03M +6,000 New
NFA
93
Nationwide Fund Advisors
Ohio
$1.07M -$339K -1,968 -26%
TG
94
TCW Group
California
$1.04M +$956K +5,558 New
UBS AM
95
UBS AM
Illinois
$965K +$114K +660 +15%
BNP Paribas Financial Markets
96
BNP Paribas Financial Markets
France
$949K +$807K +4,690 +1,285%
AP
97
AHL Partners
United Kingdom
$945K +$867K +5,037 New
RJA
98
Raymond James & Associates
Florida
$944K +$131K +764 +18%
CSS
99
Cubist Systematic Strategies
Connecticut
$886K +$813K +4,722 New
PPA
100
Parametric Portfolio Associates
Washington
$881K -$227K -1,320 -22%
2 3
4
5 6

NKTR Hedge Fund Activity: Q2 2015 in Review

181 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q2 2015, worth a combined $1.73B — up 24% from $1.39B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new NKTR positions and 23 closed out — a net gain of 28 holders — while 53 added to existing stakes and 45 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $50.7M. The largest seller was JP Morgan Chase, cutting an estimated $41.1M.

  • 181 institutional investors held Nektar Therapeutics (NKTR) as of Q2 2015, up from 153 in Q1 2015.
  • Funds reported $1.73B of Nektar Therapeutics stock for Q2 2015, up 24% quarter-over-quarter.
  • 51 funds opened new Nektar Therapeutics positions in Q2 2015 and 23 closed out, a net change of +28 holders.
  • The largest Nektar Therapeutics buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $50.7M added.
  • The largest Nektar Therapeutics seller in Q2 2015 was JP Morgan Chase, an estimated $41.1M sold.

Based on aggregated 13F filings for Q2 2015.